{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:58:04Z","timestamp":1784602684106,"version":"3.55.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.brainres.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T08:22:27Z","timestamp":1515054147000},"page":"12-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Complex noradrenergic dysfunction in Alzheimer\u2019s disease: Low norepinephrine input is not always to blame"],"prefix":"10.1016","volume":"1702","author":[{"given":"Mary","family":"Gannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1079-5914","authenticated-orcid":false,"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.01.001_b0005","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1523\/JNEUROSCI.09-11-04062.1989","article-title":"Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis","volume":"9","author":"Abercrombie","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/bjp.135.3.216","article-title":"Changes in the brain catecholamines in patients with dementia of Alzheimer type","volume":"135","author":"Adolfsson","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0091-3057(96)00477-7","article-title":"The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys","volume":"58","author":"Arnsten","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2018.01.001_b0020","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1126\/science.280.5370.1711","article-title":"The biology of being frazzled","volume":"280","author":"Arnsten","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.01.001_b0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archpsyc.55.4.362","article-title":"Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism","volume":"55","author":"Arnsten","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0022-510X(93)90198-8","article-title":"Frequency analysis of catecholamine axonal morphology in human brain. II. Alzheimer's disease and hippocampal sympathetic ingrowth","volume":"119","author":"Booze","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2018.01.001_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","article-title":"The pathological process underlying Alzheimer's disease in individuals under thirty","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2018.01.001_b0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer's pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2018.01.001_b0045","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/WCO.0b013e32835a3432","article-title":"Where, when, and in what form does sporadic Alzheimer's disease begin?","volume":"25","author":"Braak","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neurobiolaging.2012.02.031","article-title":"Age-related appearance of dendritic inclusions in catecholaminergic brainstem neurons","volume":"34","author":"Braak","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0060","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2014.06.011","article-title":"Administration of a selective beta2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Branca","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainres.2018.01.001_b0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0075","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.1073\/pnas.1409513111","article-title":"alpha(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2018.01.001_b0080","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1745-7254.2005.00224.x","article-title":"Recent progress in alpha1-adrenergic receptor research","volume":"26","author":"Chen","year":"2005","journal-title":"Acta Pharmacol Sin."},{"key":"10.1016\/j.brainres.2018.01.001_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bss0670163","article-title":"Receptor-G-protein signalling in Alzheimer's disease","author":"Cowburn","year":"2001","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.brainres.2018.01.001_b0090","doi-asserted-by":"crossref","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer's disease cerebrospinal fluid","volume":"7","author":"Czech","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2018.01.001_b0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.410220207","article-title":"Aminergic systems in Alzheimer's disease and Parkinson's disease","volume":"22","author":"D'Amato","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(90)91091-T","article-title":"Concurrent muscarinic and beta-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance","volume":"513","author":"Decker","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0165-3806(96)00071-5","article-title":"Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model","volume":"95","author":"Dierssen","year":"1996","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-8993(96)01173-0","article-title":"Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome","volume":"749","author":"Dierssen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2013.01.031","article-title":"Systemic or intra-prelimbic cortex infusion of prazosin impairs fear memory reconsolidation","volume":"244","author":"Do Monte","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0120","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1017\/S1461145713000631","article-title":"Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice","volume":"16","author":"Dobarro","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.01.001_b0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2012.06.047","article-title":"Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model","volume":"64","author":"Dobarro","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.01.001_b0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/mol.111.073734","article-title":"Long-term \u03b11A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity","volume":"80","author":"Doze","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2018.01.001_b0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1176\/ajp.154.1.25","article-title":"Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration","volume":"154","author":"Elrod","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0140","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2007.10.018","article-title":"The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia","volume":"52","author":"Engelborghs","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2018.01.001_b0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0306-4522(94)00331-X","article-title":"Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam","volume":"64","author":"Finlay","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.01.001_b0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2007-1014267","article-title":"Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease - a hypothesis","volume":"27","author":"Forstl","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnins.2015.00220","article-title":"Noradrenergic dysfunction in Alzheimer's disease","volume":"9","author":"Gannon","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000080128","article-title":"Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit?","volume":"18","author":"Giubilei","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.brainres.2018.01.001_b0170","unstructured":"Golan, D.E., Tashjian, A.H., Armstrong, E.J., 2011. Principles of pharmacology: the pathophysiologic basis of drug therapy, Vol., Lippincott Williams & Wilkins."},{"key":"10.1016\/j.brainres.2018.01.001_b0175","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1523\/JNEUROSCI.16-15-04787.1996","article-title":"Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat","volume":"16","author":"Goldstein","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0197-4580(83)90002-7","article-title":"Biochemical changes in dementia disorders of Alzheimer type (AD\/SDAT)","volume":"4","author":"Gottfries","year":"1983","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuint.2010.03.001","article-title":"The norepinephrine transporter (NET) radioligand (S, S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study","volume":"56","author":"Gulyas","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2018.01.001_b0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.semcdb.2003.12.017","article-title":"Beta-adrenergic receptors and their interacting proteins","volume":"15","author":"Hall","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.brainres.2018.01.001_b0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00702-003-0089-4","article-title":"Impairment of G(salpha) function in human brain cortex of Alzheimer's disease: comparison with normal aging","volume":"111","author":"Hashimoto","year":"2004","journal-title":"J. Neural. Transm. (Vienna)."},{"key":"10.1016\/j.brainres.2018.01.001_b0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00441-006-0285-2","article-title":"Adrenoceptors and signal transduction in neurons","volume":"326","author":"Hein","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(89)90179-2","article-title":"Monoaminergic neurotransmitters in Alzheimer's disease. An HPLC study comparing presenile familial and sporadic senile cases","volume":"92","author":"Herregodts","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2018.01.001_b0210","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T","article-title":"Increased activity of surviving locus ceruleus neurons in Alzheimer's disease","volume":"45","author":"Hoogendijk","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130050569","article-title":"A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo","volume":"136","author":"Hughes","year":"1998","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.brainres.2018.01.001_b0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(83)90171-4","article-title":"Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type","volume":"39","author":"Iversen","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.01.001_b0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","article-title":"Metabolomic changes in autopsy-confirmed Alzheimer's disease","volume":"7","author":"Kaddurah-Daouk","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.brainres.2018.01.001_b0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(89)90645-8","article-title":"Characterization of [125I]HEAT binding to alpha 1-receptors in human brain: assessment in aging and Alzheimer's disease","volume":"501","author":"Kalaria","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0235","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1471-4159.1989.tb09242.x","article-title":"Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus","volume":"53","author":"Kalaria","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.01.001_b0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3940(89)90164-X","article-title":"Brain microvessels are innervated by locus ceruleus noradrenergic neurons","volume":"97","author":"Kalaria","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.01.001_b0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/PL00004942","article-title":"Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats","volume":"355","author":"Kask","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2018.01.001_b0250","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2012.09.010","article-title":"Prazosin, an alpha(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease","volume":"34","author":"Katsouri","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0255","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.npp.1301518","article-title":"Combined but not individual administration of beta-adrenergic and serotonergic antagonists impairs water maze acquisition in the rat","volume":"33","author":"Kenton","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.01.001_b0260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuint.2007.06.036","article-title":"Alpha2-adrenoceptor subtypes\u2013unexpected functions for receptors and ligands derived from gene-targeted mouse models","volume":"51","author":"Knaus","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2018.01.001_b0265","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00169270","article-title":"Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease","volume":"347","author":"Lemmer","year":"1993","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2018.01.001_b0270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0197-4580(01)00221-4","article-title":"Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies","volume":"22","author":"Leverenz","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0275","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.136.6.533","article-title":"Changes in the monoamine containing neurones of the human CNS in senile dementia","volume":"136","author":"Mann","year":"1980","journal-title":"British J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3940(86)90336-8","article-title":"Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged","volume":"64","author":"Marcyniuk","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.01.001_b0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural. Transm. Park Dis. Dement. Sect."},{"key":"10.1016\/j.brainres.2018.01.001_b0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","article-title":"Noradrenergic changes, aggressive behavior, and cognition in patients with dementia","volume":"51","author":"Matthews","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainres.2010.12.015","article-title":"Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease","volume":"1373","author":"McMillan","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbr.2003.10.038","article-title":"Characteristics of behavioral abnormalities in alpha1d-adrenoceptors deficient mice","volume":"152","author":"Mishima","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0022-510X(84)90163-1","article-title":"Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients","volume":"63","author":"Miyata","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2018.01.001_b0310","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2013.02.002","article-title":"Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease","volume":"44","author":"Mustapic","year":"2013","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0315","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S1734-1140(13)71509-3","article-title":"alpha1-Adrenergic receptor subtypes in the central nervous system: insights from genetically engineered mouse models","volume":"65","author":"Nalepa","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainres.2018.01.001_b0320","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3233\/JAD-130608","article-title":"Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AbetaPP","volume":"38","author":"Nelson","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2018.01.001_b0325","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1485","article-title":"Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation","volume":"12","author":"Ni","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2018.01.001_b0330","first-page":"501","article-title":"Reduced cAMP-signal transduction in postmortem hippocampus of demented old people","volume":"317","author":"Ohm","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0335","first-page":"340","article-title":"Laboratory examinations correlated with severity of dementia","volume":"26","author":"Oishi","year":"1996","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.brainres.2018.01.001_b0340","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1523\/JNEUROSCI.09-11-03803.1989","article-title":"Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat","volume":"9","author":"Oleskevich","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0345","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1073\/pnas.0502315102","article-title":"A requirement for memory retrieval during and after long-term extinction learning","volume":"102","author":"Ouyang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2018.01.001_b0350","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jnnp.47.5.481","article-title":"Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia","volume":"47","author":"Palmer","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-8993(87)90018-7","article-title":"Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease","volume":"414","author":"Palmer","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0304-3940(92)90614-D","article-title":"Loss of high-affinity alpha 2-adrenoceptors in Alzheimer's disease: an autoradiographic study in frontal cortex and hippocampus","volume":"142","author":"Pascual","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.01.001_b0365","first-page":"16","article-title":"Propranolol for treatment of agitation in senile dementia","volume":"84","author":"Pauszek","year":"1991","journal-title":"Indiana Med."},{"key":"10.1016\/j.brainres.2018.01.001_b0370","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bcp.2006.09.010","article-title":"Structure-function of alpha1-adrenergic receptors","volume":"73","author":"Perez","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2018.01.001_b0375","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.1995.03950210068012","article-title":"Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine","volume":"52","author":"Peskind","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.wad.0000155067.16313.5e","article-title":"Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study","volume":"19","author":"Peskind","year":"2005","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.brainres.2018.01.001_b0385","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biopsych.2009.03.006","article-title":"Acute psychological stress reduces working memory-related activity in the dorsolateral prefrontal cortex","volume":"66","author":"Qin","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0390","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archpsyc.1984.01790150033006","article-title":"Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease","volume":"41","author":"Raskind","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.brainres.2018.01.001_b0395","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00002093-199404000-00005","article-title":"Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease","volume":"8","author":"Raskind","year":"1994","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.brainres.2018.01.001_b0400","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0006-3223(99)00008-6","article-title":"Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease","volume":"46","author":"Raskind","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0405","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(88)90179-7","article-title":"A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease","volume":"84","author":"Reinikainen","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2018.01.001_b0410","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.490270419","article-title":"Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy","volume":"27","author":"Reinikainen","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(93)90798-R","article-title":"Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease","volume":"622","author":"Ross","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pbb.2014.09.013","article-title":"Corticosterone and propranolol's role on taste recognition memory","volume":"127","author":"Ruetti","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2018.01.001_b0425","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(93)90925-B","article-title":"Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease","volume":"160","author":"Ruiz","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.01.001_b0430","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.npp.1300163","article-title":"Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists","volume":"28","author":"Saber","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.01.001_b0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00002093-199509040-00010","article-title":"Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients","volume":"9","author":"Shankle","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.brainres.2018.01.001_b0440","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.JGP.0000237065.78966.1b","article-title":"Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease","volume":"15","author":"Sharp","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0445","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1471-4159.1986.tb00753.x","article-title":"Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia","volume":"47","author":"Shimohama","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.01.001_b0450","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/JAD-2006-9107","article-title":"The management of agitation in demented patients with propranolol","volume":"9","author":"Summers","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2018.01.001_b0455","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1100\/tsw.2010.154","article-title":"Dysfunction of G protein-coupled receptor kinases in Alzheimer's disease","volume":"10","author":"Suo","year":"2010","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.brainres.2018.01.001_b0460","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4236\/aad.2013.24020","article-title":"Accelerating Alzheimer\u2019s pathogenesis by GRK5 deficiency via cholinergic dysfunction","author":"Suo","year":"2013","journal-title":"Adv. Alzheimer's Dis."},{"key":"10.1016\/j.brainres.2018.01.001_b0465","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cne.901630406","article-title":"The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker","volume":"163","author":"Swanson","year":"1975","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.01.001_b0470","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","article-title":"Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies","volume":"26","author":"Szot","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0475","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuroscience.2007.01.031","article-title":"Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes","volume":"146","author":"Szot","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.01.001_b0480","first-page":"231","article-title":"Propranolol-induced impairment of contextual fear memory reconsolidation in rats: a similar effect on weak and strong recent and remote memories","volume":"5","author":"Taherian","year":"2014","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(93)91201-3","article-title":"Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease","volume":"631","author":"Tejani-Butt","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn2977","article-title":"The role of G protein-coupled receptors in the pathology of Alzheimer's disease","volume":"12","author":"Thathiah","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm.3023","article-title":"[beta]-arrestin 2 regulates A[beta] generation and [gamma]-secretase activity in Alzheimer's disease","volume":"19","author":"Thathiah","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2018.01.001_b0500","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02257623","article-title":"Concentration of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type","volume":"4","author":"Tohgi","year":"1992","journal-title":"J. Neural Transmission - Parkinson's Dis. Dementia Sect."},{"key":"10.1016\/j.brainres.2018.01.001_b0505","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1523\/JNEUROSCI.23-05-01879.2003","article-title":"Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release","volume":"23","author":"Ventura","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.01.001_b0510","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/lm.708807","article-title":"Noradrenergic control of odor recognition in a nonassociative olfactory learning task in the mouse","volume":"14","author":"Veyrac","year":"2007","journal-title":"Learn Mem."},{"key":"10.1016\/j.brainres.2018.01.001_b0515","doi-asserted-by":"crossref","first-page":"10298","DOI":"10.1074\/jbc.M112.415141","article-title":"\u03b22 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2018.01.001_b0520","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3233\/JAD-2012-120904","article-title":"Investigation of nebivolol as a novel therapeutic agent for the treatment of Alzheimer's disease","volume":"33","author":"Wang","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2018.01.001_b0525","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","article-title":"Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression","volume":"17","author":"Wang","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.brainres.2018.01.001_b0530","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.neurobiolaging.2013.04.007","article-title":"Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span","volume":"34","author":"Wang","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0535","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2004.11.011","article-title":"Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease","volume":"27","author":"Watson","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.01.001_b0540","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-8993(99)01220-2","article-title":"Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type","volume":"824","author":"Yamamoto-Sasaki","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0545","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1097\/00001756-199611250-00033","article-title":"Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type","volume":"7","author":"Yamamoto","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2018.01.001_b0550","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF01291889","article-title":"Ca2+\/CaM-sensitive adenylyl cyclase activity is decreased in the Alzheimer's brain: possible relation to type I adenylyl cyclase","volume":"104","author":"Yamamoto","year":"1997","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.brainres.2018.01.001_b0555","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.brainres.2009.12.087","article-title":"Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production","volume":"1317","author":"Yu","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.01.001_b0560","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318300015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318300015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T08:05:21Z","timestamp":1719734721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318300015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":112,"alternative-id":["S0006899318300015"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.01.001","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex noradrenergic dysfunction in Alzheimer\u2019s disease: Low norepinephrine input is not always to blame","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}